| Title |
Monoamine depletion by reuptake inhibitors
|
|---|---|
| Published in |
Drug, Healthcare and Patient Safety, October 2011
|
| DOI | 10.2147/dhps.s24798 |
| Pubmed ID | |
| Authors |
Marty Hinz, Alvin Stein, Thomas Uncini |
| Abstract |
Disagreement exists regarding the etiology of cessation of the observed clinical results with administration of reuptake inhibitors. Traditionally, when drug effects wane, it is known as tachyphylaxis. With reuptake inhibitors, the placebo effect is significantly greater than the drug effect in the treatment of depression and attention deficit hyperactivity disorder, leading some to assert that waning of drug effects is placebo relapse, not tachyphylaxis. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 4% |
| Unknown | 51 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 9 | 17% |
| Student > Master | 9 | 17% |
| Student > Bachelor | 7 | 13% |
| Other | 7 | 13% |
| Student > Ph. D. Student | 5 | 9% |
| Other | 8 | 15% |
| Unknown | 8 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 30% |
| Agricultural and Biological Sciences | 8 | 15% |
| Psychology | 5 | 9% |
| Neuroscience | 4 | 8% |
| Nursing and Health Professions | 3 | 6% |
| Other | 6 | 11% |
| Unknown | 11 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 April 2019.
All research outputs
#15,404,780
of 25,728,855 outputs
Outputs from Drug, Healthcare and Patient Safety
#97
of 161 outputs
Outputs of similar age
#92,522
of 144,830 outputs
Outputs of similar age from Drug, Healthcare and Patient Safety
#3
of 3 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 161 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.6. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,830 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.